EVOLVE HEALTH AND PERFORMANCE LTD

Company Registration Number:
NI668053 (Northern Ireland)

Unaudited abridged accounts for the year ended 29 February 2024

Period of accounts

Start date: 01 March 2023

End date: 29 February 2024

EVOLVE HEALTH AND PERFORMANCE LTD

Contents of the Financial Statements

for the Period Ended 29 February 2024

Balance sheet
Notes

EVOLVE HEALTH AND PERFORMANCE LTD

Balance sheet

As at 29 February 2024


Notes

2024

2023


£

£
Fixed assets
Tangible assets: 3 258,397 119,521
Total fixed assets: 258,397 119,521
Current assets
Debtors:   25,740 100
Cash at bank and in hand: 11,803 22,137
Total current assets: 37,543 22,237
Creditors: amounts falling due within one year:   (134,144) (101,190)
Net current assets (liabilities): (96,601) (78,953)
Total assets less current liabilities: 161,796 40,568
Creditors: amounts falling due after more than one year:   (113,405) (37,339)
Total net assets (liabilities): 48,391 3,229
Capital and reserves
Called up share capital: 100 100
Profit and loss account: 48,291 3,129
Shareholders funds: 48,391 3,229

The notes form part of these financial statements

EVOLVE HEALTH AND PERFORMANCE LTD

Balance sheet statements

For the year ending 29 February 2024 the company was entitled to exemption under section 477 of the Companies Act 2006 relating to small companies.

The members have not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.

The directors acknowledge their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.

The members have agreed to the preparation of abridged accounts for this accounting period in accordance with Section 444(2A).

These accounts have been prepared in accordance with the provisions applicable to companies subject to the small companies regime.

The directors have chosen to not file a copy of the company’s profit & loss account.

This report was approved by the board of directors on 18 April 2024
and signed on behalf of the board by:

Name: Mr A McClelland
Status: Director

The notes form part of these financial statements

EVOLVE HEALTH AND PERFORMANCE LTD

Notes to the Financial Statements

for the Period Ended 29 February 2024

1. Accounting policies

These financial statements have been prepared in accordance with the provisions of Section 1A (Small Entities) of Financial Reporting Standard 102

EVOLVE HEALTH AND PERFORMANCE LTD

Notes to the Financial Statements

for the Period Ended 29 February 2024

2. Employees

2024 2023
Average number of employees during the period 1 1

EVOLVE HEALTH AND PERFORMANCE LTD

Notes to the Financial Statements

for the Period Ended 29 February 2024

3. Tangible Assets

Total
Cost £
At 01 March 2023 165,352
Additions 164,971
Disposals (9,800)
At 29 February 2024 320,523
Depreciation
At 01 March 2023 45,831
Charge for year 24,351
On disposals (8,056)
At 29 February 2024 62,126
Net book value
At 29 February 2024 258,397
At 28 February 2023 119,521

EVOLVE HEALTH AND PERFORMANCE LTD

Notes to the Financial Statements

for the Period Ended 29 February 2024

4. Loans to directors

During the year, the company received net loans of £12,989 (2023: £21,761) from the director. At the balance sheet date, £97,257 (2023: £84,268) remained owed by the company.

EVOLVE HEALTH AND PERFORMANCE LTD

Notes to the Financial Statements

for the Period Ended 29 February 2024

5. Related party transactions

Mr A McClelland is also a director of Evolve Fitness Business Consultancy Ltd.During the year, the company advanced net loans of £3,500 to Evolve Fitness Business Consultancy Ltd. At the balance sheet date, £3,500 remained owed to the company.